Clinical Significance of Fibrinogen and Platelet to Pre-Albumin Ratio in Predicting the Prognosis of Advanced Gastric Cancer
Huakai Tian,Zitao Liu,Zuo Zhang,Lipeng Zhang,Zhen Zong,Jiang Liu,Houqun Ying,Hui Li
DOI: https://doi.org/10.2147/jir.s412033
IF: 4.5
2023-10-03
Journal of Inflammation Research
Abstract:Huakai Tian, 1, &ast Zitao Liu, 2, &ast Zuo Zhang, 3, &ast Lipeng Zhang, 2, &ast Zhen Zong, 2 Jiang Liu, 2 Houqun Ying, 4 Hui Li 5 1 Department of General Surgery, First Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China; 2 Department of Gastrointestinal Surgery, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China; 3 Department of Obstetrics and Gynecology, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China; 4 Department of Nuclear Medicine, Jiangxi Province Key Laboratory of Laboratory Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China; 5 Department of Rheumatology and Immunology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hui Li, Department of Rheumatology and Immunology, First Affiliated Hospital of Nanchang University, 17 Yongwai Main Street, Nanchang, 330006, People's Republic of China, Tel +86-15079108591, Email Houqun Ying, Department of Nuclear Medicine, Jiangxi province Key Laboratory of Laboratory Medicine, the Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang, 330006, People's Republic of China, Tel/Fax +86 791-86300410, Email Objective: The aim of this study was to investigate the clinical significance of Fibrinogen and Platelet to Pre-albumin Ratio(FPAR) in predicting the prognosis of patients with advanced gastric cancer(AGC) and to construct a predictive model. Methods: We collected clinical data from 489 postoperative patients with AGC. FPAR was divided into high and low groups according to the receiver operating characteristic (ROC) curve. The value of FPAR in predicting the prognosis of progressive gastric cancer was analysed using univariate and multivariable Cox regression analysis and its relationship with clinicopathological features. Finally, the Overall Survival(OS) and recurrence-free survival(RFS) prediction models were constructed and validated using FPAR. Results: Univariate and multifactorial cox regression analysis showed that grade (P< 0.001), TNM-stage (P< 0.001), chemotherapy (P< 0.001), and FPAR (OR=3.054,95% CI:2.088– 4.467, P< 0.001) were independent risk factors for OS; grade (P=0.021), N-stage (P=0.024), TNM-stage (P=0.033), and FPAR (OR=2.215,95% CI:1.634– 3.003, P< 0.001) were independent risk factors for RFS. Subgroup analysis showed that the FPAR-low group had higher OS and RFS than the FPAR-high group, regardless of the patient's TNM stage (p< 0.05). However, OS was instead higher in the the stage III-FPAR-low group than in the the stage II-FPAR-high group (p< 0.05), while RFS was not significantly different. Predictive models incorporating FPAR had better predictive performance than those without FPAR, showing wide range of net benefit and AUC. After correction, the 2-year AUC, 3-year AUC and C-index of the OS model were 0.737, 0.756, and 0.746; the 2-year AUC, 3-year AUC, and C-index of the RFS model were 0.738, 0.758, and 0.711. Conclusion: FPAR levels were associated with prognosis in patients with AGC and could independently predict RFS and OS. Keywords: advanced gastric cancer, FPAR, overall survival, recurrence-free survival, prognosis Gastric cancer (GC), ranking morbidity fifth and mortality third, is one of the most common malignant tumors of the digestive system. 1,2 In recent years, although the incidence of GC has declined, the mortality is on the rise. As we all know, except for early GC, the prognosis of AGC is poor. Although radical surgical resection combined with adjuvant therapy, including targeted, immune and other comprehensive treatments are currently used, the 5-year survival rate of AGC is still less than 50%. 3 It has been reported that over 70% of tumour-related deaths in patients with gastric cancer are related to tumour recurrence and metastasis. 4 Therefore, accurate judgment of the recurrence and metastasis risk and prognosis of gastric cancer patients will help guide the diagnosis and treatment plan. It is well known that the development of gastric cancer is an extremely complex process, closely related to systemic inflammation, immunity, nutritional status and other factors. 5 It has been shown that inflammation plays an important role in the tumour microenvironment and is closely related to the occurrence, development, infiltration and metastasis of tumors, and variou -Abstract Truncated-
immunology